Cancer survival rates are usually discussed in terms of 5-year relative survival, which refers to the proportion of patients still alive 5 years after diagnosis. Keep in mind that statistics like these are based on large groups of people and cannot predict what might happen with an individual patient.
Overall, the five-year survival rate for women with uterine cancer is 81%, however, statistics show marked differences, called cancer health disparities, between white women and black women. Among white women, the five-year survival is 84%, compared to 62% for black women. Black women are less likely to have their disease diagnosed at an early stage, and they are more likely to develop more aggressive and difficult to treat cancer types.
The causes of disparities such as these are complex and are the focus of ongoing research across the country, including here at Roswell Park.
Make an appointment Learn more
Survival is largely dependent on your cancer’s stage at the time of diagnosis, and data from the National Cancer Institute show these survival rates for uterine cancer:
Stage of disease at diagnosis | Five-year survival rate |
|---|---|
Localized disease (such as stage 1 and stage 2) where the cancer was confined to the original location | 95% |
Regional disease (such as stage 3) | 70% |
Distant disease (stage 4) where the cancer has already spread to other body areas | 19% |
How Roswell Park optimizes your survival
As a national leader in cancer care, Roswell Park’s approach includes several components that maximize survival and quality of life, including:
- High-volume expertise in complex gynecologic surgery
- Clinical trials of the latest emerging approaches, such as cellular therapies, novel antibody drug conjugates, targeted drugs, and new options for chemotherapy-resistant and RAS-mutated disease.
- High Risk GYN Program that provides genetic screening, advanced surveillance and preventive options to women at high risk for developing ovarian and other gynecologic cancers